These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27997502)

  • 21. Anti-phosphohistone H3 as an independent prognostic factor in human esophageal squamous cell carcinoma.
    Nakashima S; Shiozaki A; Ichikawa D; Komatsu S; Konishi H; Iitaka D; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Otsuji E
    Anticancer Res; 2013 Feb; 33(2):461-7. PubMed ID: 23393337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of counting positive PHH3 cells in the diagnosis of uterine smooth muscle tumors.
    Pang SJ; Li CC; Shen Y; Liu YZ; Shi YQ; Liu YX
    Int J Clin Exp Pathol; 2015; 8(5):4418-26. PubMed ID: 26191133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting short-term recurrence in pituitary adenomas: Phosphohistone-H3 (Ser 10) proves an effective biomarker.
    Li C; Wei L; Li L; Wang J; Li R; Zhang Q; Zhou D
    Clin Neuropathol; 2020; 39(2):70-79. PubMed ID: 31724532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylated Histone H3 (PHH3) as a Novel Cell Proliferation Marker and Prognosticator for Meningeal Tumors: A Short Review.
    Elmaci İ; Altinoz MA; Sari R; Bolukbasi FH
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):627-631. PubMed ID: 28777144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?
    Solomides CC; Birbe RC; Nicolaou N; Bagley D; Bibbo M
    Acta Cytol; 2012; 56(3):285-8. PubMed ID: 22555531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of tumour proliferation by use of the mitotic activity index, and Ki67 and phosphohistone H3 expression, in early-stage luminal breast cancer.
    van Steenhoven JEC; Kuijer A; Kornegoor R; van Leeuwen G; van Gorp J; van Dalen T; van Diest PJ
    Histopathology; 2020 Oct; 77(4):579-587. PubMed ID: 32557844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas.
    Kim YJ; Ketter R; Steudel WI; Feiden W
    Am J Clin Pathol; 2007 Jul; 128(1):118-25. PubMed ID: 17580279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Utility of Phosphohistone H3 in Inter-Observer Variability of Mitotic Count in Meningioma, is There Any Benefit?
    Saffar H; Okhovat H; Arbabsoleymani S; Tavangar SM; Khoshnevisan A; Hajinasrollah G; Hamidi Afra Z; Saffar H
    Asian Pac J Cancer Prev; 2021 Jul; 22(7):2049-2052. PubMed ID: 34319026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of PHH3 in Evaluation of Mitotic Index in Breast Carcinoma and Impact on Tumor Grade.
    Mirzaiian E; Tabatabaei Ghods ZS; Tavangar SM; Emami B; Oraie M; Safyari R; Saffar H
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):63-66. PubMed ID: 31983165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interobserver variability of mitotic index and utility of PHH3 for risk stratification in gastrointestinal stromal tumors.
    Alkhasawneh A; Reith JD; Toro TZ; Ayed AO; Lu X; George TJ; Duckworth LV
    Am J Clin Pathol; 2015 Mar; 143(3):385-92. PubMed ID: 25696796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunostaining of phospho-histone H3 and Ki-67 improves reproducibility of recurrence risk assessment of gastrointestinal stromal tumors.
    Uguen A; Conq G; Doucet L; Talagas M; Costa S; De Braekeleer M; Marcorelles P
    Virchows Arch; 2015 Jul; 467(1):47-54. PubMed ID: 25823616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphohistone-H3 Proliferation Index Is Superior to Mitotic Index and MIB-1 Expression as a Predictor of Recurrence in Human Meningiomas.
    Winther TL; Arnli MB; Salvesen Ø; Torp SH
    Am J Clin Pathol; 2016 Oct; 146(4):510-20. PubMed ID: 27686177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study.
    Veras E; Malpica A; Deavers MT; Silva EG
    Int J Gynecol Pathol; 2009 Jul; 28(4):316-21. PubMed ID: 19483635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic importance of mitosis quantification and PHH3 expression in oral epithelial dysplasia.
    Sathyamoorthy H; Mahmood H; Zubir AZA; Hankinson P; Khurram SA
    Virchows Arch; 2024 Jan; 484(1):47-59. PubMed ID: 37882821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphohistone-H3 and Ki-67 immunostaining in cutaneous pilar leiomyoma and leiomyosarcoma (atypical intradermal smooth muscle neoplasm).
    Idriss MH; Kazlouskaya V; Malhotra S; Andres C; Elston DM
    J Cutan Pathol; 2013 Jun; 40(6):557-63. PubMed ID: 23550775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphohistone H3 and Ki-67 labeling indices in cytologic specimens from well-differentiated neuroendocrine tumors of the gastrointestinal tract and pancreas: a comparative analysis using automated image cytometry.
    Fung AD; Cohen C; Kavuri S; Lawson D; Gao X; Reid MD
    Acta Cytol; 2013; 57(5):501-8. PubMed ID: 24021213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Grading and Prognostication of Neuroendocrine Tumors of the Pancreas: A Comparison Study of Ki67 and PHH3.
    Tracht J; Zhang K; Peker D
    J Histochem Cytochem; 2017 Jul; 65(7):399-405. PubMed ID: 28651471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of Phosphohistone H3 as a cell proliferation marker in oral squamous cell carcinoma. A comparative study with Ki-67 and the mitotic activity index.
    Tancredi-Cueto N; Vigil-Bastitta G; Bologna-Molina R; Beovide-Cortegoso V
    Med Oral Patol Oral Cir Bucal; 2022 Sep; 27(5):e444-e451. PubMed ID: 35975799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PHH3 as an Ancillary Mitotic Marker in Gastrointestinal Stromal Tumors.
    Shin Y; Hyeon J; Lee B; Ha SY; Hong ME; Do IG; Kim KM
    J Pathol Transl Med; 2015 Jan; 49(1):23-9. PubMed ID: 25812654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.